SNDL Inc.
General ticker "SNDL" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $451.3M (TTM average)
SNDL Inc. follows the US Stock Market performance with the rate: 0.2%.
Estimated limits based on current volatility of 2.0%: low 1.41$, high 1.47$
Factors to consider:
- Total employees count: 1064 as of 2019
- Current price 11.8% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.63$, 2.90$]
- 2026-12-31 to 2027-12-31 estimated range: [1.64$, 2.93$]
Financial Metrics affecting the SNDL estimates:
- Positive: with PPE of -45.3 at the end of fiscal year the price was neutral
- Positive: 6.59 < Operating cash flow per share per price, % of 11.05
- Positive: -5.39 < Operating profit margin, % of -0.46
- Positive: Investing cash flow per share per price, % of 2.72 > -0.60
- Positive: Inventory ratio change, % of -0.21 <= 0
- Positive: -3.75 < Return on assets ratio (scaled to [-100,100]) of -1.17
- Positive: Interest expense per share per price, % of 1.17 <= 3.31
Short-term SNDL quotes
Long-term SNDL plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | CA$909.01MM | CA$920.45MM | CA$946.40MM |
| Operating Expenses | CA$1,072.18MM | CA$1,024.26MM | CA$950.82MM |
| Operating Income | CA$-163.17MM | CA$-103.81MM | CA$-4.42MM |
| Non-Operating Income | CA$-8.85MM | CA$-1.80MM | CA$-11.35MM |
| Interest Expense | CA$7.92MM | CA$7.70MM | CA$7.52MM |
| R&D Expense | CA$0.32MM | CA$0.35MM | CA$0.49MM |
| Income(Loss) | CA$-172.02MM | CA$-105.61MM | CA$-15.77MM |
| Taxes | CA$0.00MM | CA$-9.40MM | CA$0.00MM |
| Net Income(Loss)* | CA$-172.02MM | CA$-94.80MM | CA$-15.77MM |
| Stockholders Equity | CA$1,212.07MM | CA$1,133.36MM | CA$1,102.30MM |
| Inventory | CA$129.49MM | CA$129.11MM | CA$130.13MM |
| Assets | CA$1,473.16MM | CA$1,349.24MM | CA$1,337.26MM |
| Operating Cash Flow | CA$-16.65MM | CA$54.91MM | CA$70.92MM |
| Capital expenditure | CA$7.93MM | CA$11.02MM | CA$12.81MM |
| Investing Cash Flow | CA$-24.82MM | CA$17.76MM | CA$17.45MM |
| Financing Cash Flow | CA$-43.08MM | CA$-49.36MM | CA$-54.49MM |
| Earnings Per Share** | CA$-0.66 | CA$-0.36 | CA$-0.06 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.